Pfizer Inc. has laid the groundwork to continue its reign as the biggest of the big pharma companies with the industry’s largest array of new drug and biologic applications for US FDA approval. Seven novel agents from Pfizer are currently under review, according to the Pink Sheet’s US FDA Performance Tracker.
Pfizer and BioNTech SE’s COVID-19 vaccine Comirnaty is responsible in no small part for the company’s seat at the top of the Scrip 100 rankings by global pharmaceutical sales,...